vs

Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Limbach Holdings, Inc. (LMB). Click either name above to swap in a different company.

Limbach Holdings, Inc. is the larger business by last-quarter revenue ($186.9M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 30.1%). Over the past eight quarters, Limbach Holdings, Inc.'s revenue compounded faster (25.3% CAGR vs 10.6%).

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.

ESPR vs LMB — Head-to-Head

Bigger by revenue
LMB
LMB
1.1× larger
LMB
$186.9M
$168.4M
ESPR
Growing faster (revenue YoY)
ESPR
ESPR
+113.6% gap
ESPR
143.7%
30.1%
LMB
Faster 2-yr revenue CAGR
LMB
LMB
Annualised
LMB
25.3%
10.6%
ESPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESPR
ESPR
LMB
LMB
Revenue
$168.4M
$186.9M
Net Profit
$12.3M
Gross Margin
25.7%
Operating Margin
50.6%
9.4%
Net Margin
6.6%
Revenue YoY
143.7%
30.1%
Net Profit YoY
25.0%
EPS (diluted)
$0.32
$1.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESPR
ESPR
LMB
LMB
Q4 25
$168.4M
$186.9M
Q3 25
$87.3M
$184.6M
Q2 25
$82.4M
$142.2M
Q1 25
$65.0M
$133.1M
Q4 24
$69.1M
$143.7M
Q3 24
$51.6M
$133.9M
Q2 24
$73.8M
$122.2M
Q1 24
$137.7M
$119.0M
Net Profit
ESPR
ESPR
LMB
LMB
Q4 25
$12.3M
Q3 25
$-31.3M
$8.8M
Q2 25
$-12.7M
$7.8M
Q1 25
$-40.5M
$10.2M
Q4 24
$9.8M
Q3 24
$-29.5M
$7.5M
Q2 24
$-61.9M
$6.0M
Q1 24
$61.0M
$7.6M
Gross Margin
ESPR
ESPR
LMB
LMB
Q4 25
25.7%
Q3 25
24.2%
Q2 25
28.0%
Q1 25
27.6%
Q4 24
30.3%
Q3 24
27.0%
Q2 24
27.4%
Q1 24
26.1%
Operating Margin
ESPR
ESPR
LMB
LMB
Q4 25
50.6%
9.4%
Q3 25
-11.4%
7.2%
Q2 25
8.6%
7.5%
Q1 25
-34.0%
5.9%
Q4 24
-6.4%
9.1%
Q3 24
-31.0%
8.1%
Q2 24
3.5%
6.7%
Q1 24
52.5%
5.5%
Net Margin
ESPR
ESPR
LMB
LMB
Q4 25
6.6%
Q3 25
-35.9%
4.8%
Q2 25
-15.4%
5.5%
Q1 25
-62.2%
7.7%
Q4 24
6.9%
Q3 24
-57.2%
5.6%
Q2 24
-83.9%
4.9%
Q1 24
44.3%
6.4%
EPS (diluted)
ESPR
ESPR
LMB
LMB
Q4 25
$0.32
$1.01
Q3 25
$-0.16
$0.73
Q2 25
$-0.06
$0.64
Q1 25
$-0.21
$0.85
Q4 24
$-0.14
$0.81
Q3 24
$-0.15
$0.62
Q2 24
$-0.33
$0.50
Q1 24
$0.34
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESPR
ESPR
LMB
LMB
Cash + ST InvestmentsLiquidity on hand
$167.9M
$11.3M
Total DebtLower is stronger
$30.5M
Stockholders' EquityBook value
$-302.0M
$195.7M
Total Assets
$465.9M
$381.1M
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESPR
ESPR
LMB
LMB
Q4 25
$167.9M
$11.3M
Q3 25
$92.4M
$9.8M
Q2 25
$86.1M
$38.9M
Q1 25
$114.6M
$38.1M
Q4 24
$144.8M
$44.9M
Q3 24
$144.7M
$51.2M
Q2 24
$189.3M
$59.5M
Q1 24
$226.6M
$48.2M
Total Debt
ESPR
ESPR
LMB
LMB
Q4 25
$30.5M
Q3 25
$56.3M
Q2 25
$28.4M
Q1 25
$23.7M
Q4 24
$23.6M
Q3 24
$20.5M
Q2 24
$19.7M
Q1 24
$19.4M
Stockholders' Equity
ESPR
ESPR
LMB
LMB
Q4 25
$-302.0M
$195.7M
Q3 25
$-451.4M
$181.6M
Q2 25
$-433.5M
$170.5M
Q1 25
$-426.2M
$161.1M
Q4 24
$-388.7M
$153.5M
Q3 24
$-370.2M
$142.2M
Q2 24
$-344.2M
$133.0M
Q1 24
$-294.3M
$125.5M
Total Assets
ESPR
ESPR
LMB
LMB
Q4 25
$465.9M
$381.1M
Q3 25
$364.0M
$409.1M
Q2 25
$347.1M
$343.0M
Q1 25
$324.0M
$336.4M
Q4 24
$343.8M
$352.1M
Q3 24
$314.1M
$324.4M
Q2 24
$352.3M
$303.9M
Q1 24
$373.1M
$289.2M
Debt / Equity
ESPR
ESPR
LMB
LMB
Q4 25
0.16×
Q3 25
0.31×
Q2 25
0.17×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.14×
Q2 24
0.15×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESPR
ESPR
LMB
LMB
Operating Cash FlowLast quarter
$45.2M
$28.1M
Free Cash FlowOCF − Capex
$27.9M
FCF MarginFCF / Revenue
14.9%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
2.29×
TTM Free Cash FlowTrailing 4 quarters
$41.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESPR
ESPR
LMB
LMB
Q4 25
$45.2M
$28.1M
Q3 25
$-4.3M
$13.3M
Q2 25
$-31.4M
$2.0M
Q1 25
$-22.6M
$2.2M
Q4 24
$-35.0M
$19.3M
Q3 24
$-35.3M
$4.9M
Q2 24
$-7.2M
$16.5M
Q1 24
$53.8M
$-3.9M
Free Cash Flow
ESPR
ESPR
LMB
LMB
Q4 25
$27.9M
Q3 25
$12.8M
Q2 25
$1.2M
Q1 25
$11.0K
Q4 24
$18.0M
Q3 24
$-35.5M
$4.6M
Q2 24
$-7.3M
$13.2M
Q1 24
$53.8M
$-6.5M
FCF Margin
ESPR
ESPR
LMB
LMB
Q4 25
14.9%
Q3 25
7.0%
Q2 25
0.8%
Q1 25
0.0%
Q4 24
12.5%
Q3 24
-68.7%
3.4%
Q2 24
-9.9%
10.8%
Q1 24
39.0%
-5.5%
Capex Intensity
ESPR
ESPR
LMB
LMB
Q4 25
0.0%
0.1%
Q3 25
0.0%
0.3%
Q2 25
0.0%
0.6%
Q1 25
0.0%
1.7%
Q4 24
0.0%
0.9%
Q3 24
0.3%
0.3%
Q2 24
0.1%
2.7%
Q1 24
0.1%
2.1%
Cash Conversion
ESPR
ESPR
LMB
LMB
Q4 25
2.29×
Q3 25
1.52×
Q2 25
0.26×
Q1 25
0.22×
Q4 24
1.96×
Q3 24
0.66×
Q2 24
2.77×
Q1 24
0.88×
-0.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

LMB
LMB

Owner Direct Relationships Segment$145.0M78%
General Contractor Construction Manager Relationships Segment$41.9M22%

Related Comparisons